Jeffrey M Drazen. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedClinical Trials as TopicCrohn Disease/drug therapyHumansJC VirusLeukoencephalopathy, Progressive Multifocal/chemically inducedMultiple Sclerosis, Relapsing-Remitting/drug therapyNatalizumabRisk
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedNatalizumab
Year: 2005 PMID: 15947081 DOI: 10.1056/NEJMe058123
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245